Decoding survival in MASLD: the dominant role of metabolic factors
This study highlights the clinical value of relevant metabolic factors in predicting survival in the MASLD patient population. Related metabolic factors can be used as surrogate biomarkers for the follow-up of MASLD patients.
Authors
- Shan Zhong (ORCID: https://orcid.org/0000-0002-0455-4989)
- Zhiqiang Jin (ORCID: https://orcid.org/0000-0003-0353-4852)
- Yang Yang (ORCID: https://orcid.org/0000-0003-3050-5993)
- Cheng Zeng (ORCID: https://orcid.org/0000-0002-2027-5090)
- Zhi Zhou
Institutions
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1186/s13098-025-01802-9
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Natural Science Foundation of China
- Chongqing Medical University
- Chongqing Municipal Education Commission
- Centre Scientifique et Technique du Bâtiment